03/27/2024

In Thin Trading Week, the Dow Outperforms Wall Street

It was boosted by strong gains in Merck

On Wednesday, the Dow outpaced Wall Street peers in lean trading, boosted by strong gains in drugmaker Merck, while investors awaited crucial economic data and commentary from the central bank's policymakers with the long holiday weekend approaching.

Merck advanced 3.7 percent after the U.S. Food and Drug Administration (FDA) approved its therapy for adults suffering from a rare lung condition.

At current levels, the blue-chip Dow is around 1 percent shy of the 40,000-point mark, which it has never breached.

Please select this link to read the complete article from Reuters.